Carcinoembryonic Antigen (CEA) Market: Cancer Biomarker Testing, Diagnostic Kits, and Monitoring Applications in Oncology
Executive Summary:  The Global Carcinoembryonic Antigen (CEA) Market is a vital segment within the cancer diagnostics and tumor marker industry. CEA is a glycoprotein primarily used as a non-specific serum biomarker to monitor treatment efficacy, detect disease recurrence, and provide prognostic information for several cancers, most notably colorectal cancer (CRC). The market is...
0 Comments 0 Shares 45 Views 0 Reviews